Connexion
E-mail
Mot de passe
Afficher le mot de passe
Retenir
Mot de passe oublié ?
Devenir membre gratuitement
Inscription
Inscription
Devenir membre
Inscription gratuite
Devenir client
Découvrez nos services
Paramètres
Paramètres
Cotations dynamiques 
OFFON

IBIO, INC.

(IBIO)
  Rapport
SynthèseCotationsGraphiquesActualitésNotationsAgendaSociétéFinancesConsensusRévisionsDérivésFondsCommunauté 
SynthèseToute l'actualitéReco analystesAutres languesCommuniquésPublications officiellesActualités du secteur
Actualités dans d'autres langues sur IBIO, INC.
30/11ISS Joins Glass Lewis in Recommending Shareholders Vote “FOR” All Proposals..
29/11Omicron Variant Underscores Need for New COVID Vaccine Candidates Like IBIO-202
29/11IBio, Inc Announces Update for its Lead COVID-19 Vaccine Program, IBIO-202, in Light of..
17/11Leading Independent Proxy Advisory Firm, Glass Lewis, Recommends iBio Shareholders Vote..
15/11IBIO : Reports Fiscal First Quarter 2022 Financial Results and Provides Corporate Update -..
15/11IBIO, INC. Management's Discussion and Analysis of Financial Condition and Results of ..
15/11Earnings Flash (IBIO) IBIO Reports Q1 Revenue $211,000
15/11IBio Reports Fiscal First Quarter 2022 Financial Results and Provides Corporate Update
15/11IBio, Inc. Reports Earnings Results for the First Quarter Ended September 30, 2021
15/11IBio Announces Collaboration with UT Southwestern to Investigate IBIO-100 in Solid Tumo..
15/11IBio Announces Collaboration with The University of Texas Southwestern Medical Center t..
08/11IBio to Report Fiscal 2022 First Quarter Financial Results and Provide Corporate Update..
04/11IBio Acquires FastPharming Manufacturing Facility® - Form 8-K
04/11IBIO, INC. : Entry into a Material Definitive Agreement, Termination of a Material Definit..
03/11iBio Acquires FastPharming Manufacturing Facility®
26/10IBio Urges Shareholders to Vote “FOR” All Proposals Ahead of its Upcoming A..
28/09IBIO : Management's Discussion and Analysis of Financial Condition and Results of Operatio..
27/09IBIO : Reports Fourth Quarter and Fiscal Year 2021 Financial Results and Provides Corporat..
27/09IBio, Inc. Provides Revenue Guidance for the First Half, Second Half and Full Year of F..
27/09IBIO : Earnings Flash (IBIO) IBIO Reports Q4 Revenue $0.5M
27/09iBio Reports Fourth Quarter and Fiscal Year 2021 Financial Results and Provides Corpora..
27/09Ibio, Inc. Reports Earnings Results for the Full Year Ended June 30, 2021
27/09NORTH AMERICAN MORNING BRIEFING : Stock Futures -2-
20/09IBIO : to Participate in the Cantor 2021 Virtual Global Healthcare Conference
20/09iBio to Report Fiscal Fourth Quarter and Full Year 2021 Financial Results and Provide C..
07/09iBio Announces Participation in H.C. Wainwright 23rd Annual Global Investment Conferenc..
31/08IBIO, INC. : Change in Directors or Principal Officers (form 8-K)
31/08Seymour Flug Resigns as Director of iBio, Inc
30/08IBIO, INC. : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)
27/08IBIO : THIRD AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF RUBRYC THERAPEUTICS, INC..
27/08IBIO, INC. : Entry into a Material Definitive Agreement, Financial Statements and Exhibits..
27/08IBIO : Industry veteran adds deep expertise in immuno-oncology to the Board (Form 8-K)
26/08IBIO, INC. : Change in Directors or Principal Officers, Regulation FD Disclosure, Financia..
26/08IBIO : Appoints William D. Clark to its Board of Directors
26/08IBio, Inc. Appoints William D. Clark to Its Board of Directors
25/08IBIO : Signs Licence Agreement With RubrYc Therapeutics for Immunotherapy Candidate RTX-00..
25/08IBIO : Expands Immuno-Oncology Pipeline in AI Partnership with RubrYc Therapeutics
23/08RubrYc Therapeutics Inc. announced that it expects to receive $7.500001 million in fund..
16/07SECTOR UPDATE : Health Care Stocks Eke Out Small Gains In Premarket Friday
16/07IBio's COVID-19 Vaccine Candidate Shows T-Cell Response in Preclinical Studies; Shares ..
16/07IBIO : Reports Successful Preclinical Immunization Studies with Next-Gen Nucleocapsid COVI..
16/07IBIO, INC. : Regulation FD Disclosure, Other Events, Financial Statements and Exhibits (fo..
15/07IBIO : Reports Successful Preclinical Immunization Studies with Next-Gen Nucleocapsid COVI..
15/07IBio Reports Successful Preclinical Immunization Studies with Next-Gen Nucleocapsid COV..
09/07SECTOR UPDATE : Health Care Stocks Cautiously Higher Ahead of Friday Opener
08/07IBIO : Adds Three New Antibody Programs to Pipeline -- Stock Jumps 8% After-Hours
08/07iBio Establishes Oncology Drug Discovery Pipeline with Three New Antibody Programs
08/07IBio, Inc. Establishes Oncology Drug Discovery Pipeline with Three New Antibody Program..
25/06IBIO, INC.(NYSEAM : IBIO) dropped from Russell Microcap Growth Index
25/06IBIO, INC.(NYSEAM : IBIO) dropped from Russell 3000E Growth Index
25/06IBIO, INC.(NYSEAM : IBIO) dropped from Russell 3000 Growth Index
25/06IBIO, INC.(NYSEAM : IBIO) dropped from Russell Small Cap Comp Growth Index
25/06IBIO, INC.(NYSEAM : IBIO) dropped from Russell 2500 Growth Index
25/06IBIO, INC.(NYSEAM : IBIO) dropped from Russell 2000 Growth Index
09/06IBIO : Further Strengthens Board with Appointment of Veteran Biopharmaceutical Executive, ..
09/06IBIO, INC. : Change in Directors or Principal Officers, Other Events, Financial Statements..
09/06iBio Further Strengthens Board with Appointment of Veteran Biopharmaceutical Executive,..
09/06IBio Appoints Evert Schimmelpennink to the Board of Directors
19/05iBio to Present at the UBS Global Healthcare Virtual Conference
17/05IBIO : Management's Discussion and Analysis of Financial Condition and Results of Operatio..
17/05IBIO : Earnings Flash (IBIO) IBIO Reports Q3 Revenue $765,000, vs. Street Est of $0.8M
17/05IBIO : Reports Fiscal Third Quarter 2021 Financial Results and Provides Corporate Update
17/05Ibio, Inc. Reports Earnings Results for the Third Quarter Ended March 31, 2021
10/05iBio to Report Fiscal 2021 Third Quarter Financial Results and Provide Corporate Update..
07/05SECTOR UPDATE : Health Care Stocks Get Friday Boost From Biotech Shares
07/05SECTOR UPDATE : Health Care Stocks Rise as Biotech Shines
06/05IBIO, INC. : Change in Directors or Principal Officers, Regulation FD Disclosure, Other Ev..
06/05IBIO : Reports Successful COVID-19 Vaccine Toxicology Study Results and Announces Next-Gen..
06/05IBio, Inc. Reports Successful Covid-19 Vaccine Toxicology Study Results and Announces N..
05/05SECTOR UPDATE : Health Care Stocks Holding Onto Slim Gains
05/05SECTOR UPDATE : Health Care Stocks Fighting to Stay on Positive Ground
04/05IBIO, INC. : Entry into a Material Definitive Agreement (form 8-K)
04/05iBio and Fraunhofer USA Conclude Litigation and Enter License Agreement
09/03iBio to Participate in the 33rd Annual Roth Conference
09/03Certain Stock Options of iBio, Inc. are subject to a Lock-Up Agreement Ending on 9-MAR-..
1  2  3  4  5Suiv.
Prochain événement sur IBIO, INC.